X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24) 24
humans (20) 20
silibinin (12) 12
cancer (11) 11
cell line, tumor (11) 11
cancer stem cells (10) 10
female (9) 9
cell biology (8) 8
metformin (8) 8
cell proliferation - drug effects (7) 7
lung cancer (7) 7
research paper (7) 7
biochemistry & molecular biology (6) 6
carcinoma, non-small-cell lung - drug therapy (6) 6
mutation (6) 6
neoplastic stem cells - drug effects (6) 6
antineoplastic agents - pharmacology (5) 5
breast cancer (5) 5
breast-cancer (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
drug-resistance (5) 5
epithelial-mesenchymal transition - drug effects (5) 5
metabolism (5) 5
neoplastic stem cells - pathology (5) 5
acquired-resistance (4) 4
cells (4) 4
drug resistance, neoplasm - drug effects (4) 4
drug synergism (4) 4
egfr (4) 4
expression (4) 4
insulin (4) 4
lung neoplasms - pathology (4) 4
neoplasms (4) 4
neoplastic stem cells - metabolism (4) 4
phenotype (4) 4
protein kinase inhibitors - pharmacology (4) 4
respiratory tract diseases (4) 4
signal transduction - drug effects (4) 4
silymarin - administration & dosage (4) 4
treatment outcome (4) 4
administration, oral (3) 3
aged (3) 3
aldefluor (3) 3
animals (3) 3
brca1 (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - pathology (3) 3
chemotherapy (3) 3
denosumab (3) 3
diabetes (3) 3
dose-response relationship, drug (3) 3
drug resistance, neoplasm (3) 3
e-cadherin (3) 3
epithelial-mesenchymal transition (3) 3
erlotinib (3) 3
erlotinib hydrochloride (3) 3
food science & technology (3) 3
legasil (3) 3
male (3) 3
mcf-7 cells (3) 3
metastasis (3) 3
metformin - therapeutic use (3) 3
middle aged (3) 3
milk thistle (3) 3
molecular targeted therapy (3) 3
mutations (3) 3
neoplasms - drug therapy (3) 3
oncology (3) 3
rank (3) 3
rankl (3) 3
receptor, epidermal growth factor - antagonists & inhibitors (3) 3
receptor, epidermal growth factor - metabolism (3) 3
research (3) 3
silymarin - pharmacology (3) 3
stat3 (3) 3
toxicology (3) 3
transfection (3) 3
tumor-growth (3) 3
tyrosine kinase inhibitors (3) 3
acetyl-coa carboxylase (2) 2
acetyl-coa carboxylase - antagonists & inhibitors (2) 2
acetyl-coa carboxylase - genetics (2) 2
acetyl-coa carboxylase - metabolism (2) 2
activation (2) 2
adult (2) 2
aldehyde dehydrogenase - metabolism (2) 2
analysis (2) 2
anaplerosis (2) 2
anti-egfr therapy (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic agents, phytogenic - administration & dosage (2) 2
antineoplastic agents, phytogenic - adverse effects (2) 2
antioxidants - pharmacology (2) 2
apoptosis - drug effects (2) 2
article (2) 2
articles (2) 2
biguanides (2) 2
brain edema - diagnosis (2) 2
brain edema - prevention & control (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of optics, ISSN 2040-8978, 07/2016, Volume 18, Issue 8, p. 83001
Information security and authentication are important challenges facing society. Recent attacks by hackers on the databases of large commercial and financial... 
OBJECT AUTHENTICATION | NEAR-FIELD INTERACTIONS | ASYMMETRIC CRYPTOSYSTEM | INFORMATION ENCRYPTION | FRESNEL DOMAIN | SHIFTING DIGITAL HOLOGRAPHY | DOUBLE-IMAGE ENCRYPTION | OPTICS | RANDOM-PHASE ENCRYPTION | TRUNCATED FOURIER-TRANSFORMS | PLAINTEXT ATTACK
Journal Article
Nutrients, ISSN 2072-6643, 07/2019, Volume 11, Issue 7, p. 1656
The lysine-specific histone demethylase 1A (LSD1) also known as lysine (K)-specific demethylase 1A (KDM1A) is a central epigenetic regulator of metabolic... 
SOX2 | secoiridoids | neurological disorders | cancer | metabolism | cancer stem cells | phenolics
Journal Article
Scientific Reports, ISSN 2045-2322, 2013, Volume 3, Issue 1, pp. 2560 - 2560
Journal Article
Scientific Reports, ISSN 2045-2322, 2013, Volume 3, Issue 1, pp. 1 - 10
Journal Article
Cell Cycle, ISSN 1538-4101, 11/2015, Volume 14, Issue 22, pp. 3527 - 3532
Journal Article
Cell Cycle, ISSN 1538-4101, 11/2013, Volume 12, Issue 21, pp. 3390 - 3404
The enrichment of cancer stem cell (CSC)-like cellular states has not previously been considered to be a causative mechanism in the generalized progression of... 
ALDEFLUOR | Erlotinib | Cancer stem cells | Lung cancer | Silibinin | EGFR | lung cancer | silibinin | Report | erlotinib | cancer stem cells
Journal Article
FRONTIERS IN ENDOCRINOLOGY, ISSN 1664-2392, 11/2018, Volume 9, pp. 657 - 657
Metformin has been proposed to operate as an agonist of SIRT1, a nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase that mimics most of the... 
ACTIVATED PROTEIN-KINASE | LIPID-METABOLISM | MECHANISM | ELEGANS LIFE-SPAN | metformin | SIRT1 | INSULIN SENSITIVITY | SIRT1 ACTIVATORS | STRUCTURAL BASIS | ALLOSTERIC ACTIVATORS | ENDOCRINOLOGY & METABOLISM | NAD(+) | AGE-RELATED DISEASES | aging | NAD loss | TUMOR-GROWTH | Computer-generated environments | Metformin | Computer simulation | Analysis | NAD
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 06/2018, Volume 116, Issue Pt B, pp. 161 - 172
We herein combined experimental and computational efforts to delineate the mechanism of action through which the flavonolignan silibinin targets STAT3.... 
Metastasis | Silibinin | STAT3 | Cancer | CELLS | FEEDBACK ACTIVATION | TYROSINE PHOSPHORYLATION | SMALL-MOLECULE | TARGETING STAT3 | FOOD SCIENCE & TECHNOLOGY | DRUG-RESISTANCE | BREAST-CANCER | MILK THISTLE | PROSTATE-CANCER | TOXICOLOGY | TUMOR-GROWTH | Molecular dynamics | Genetic transcription | Nucleotide sequencing | DNA sequencing | Index Medicus
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 10/2019, Volume 132, pp. 110645 - 110645
The flavonolignan silibinin is the major component of the extract isolated from the seeds of the milk thistle ( ). Herein, we performed an analysis focusing on... 
Hsp90 | Silibinin | Cancer | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 50, pp. 82185 - 82199
KRAS mutations are an established predictor of lack of response to EGFR-targeted therapies in patients with metastatic colorectal cancer (mCRC). However,... 
NRAS | KRAS | Colon cancer | Cetuximab | MEK1/2 | CELLS | ACTIVATION | N-RAS | colon cancer | ACQUIRED-RESISTANCE | cetuximab | ANTI-EGFR THERAPY | PROLIFERATION | MECHANISMS | CELL BIOLOGY | COLON-CANCER | MUTATIONS | PROGRESSION | Niacinamide - analogs & derivatives | Phosphorylation | Apoptosis - drug effects | Colorectal Neoplasms - genetics | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Receptor, Epidermal Growth Factor - metabolism | Transfection | Colorectal Neoplasms - drug therapy | Pyrimidinones - pharmacology | Proteomics - methods | MAP Kinase Kinase 1 - antagonists & inhibitors | Colorectal Neoplasms - enzymology | Membrane Proteins - genetics | Cetuximab - pharmacology | MAP Kinase Kinase 1 - metabolism | MAP Kinase Kinase 2 - metabolism | Drug Synergism | Drug Resistance, Neoplasm - genetics | Signal Transduction - drug effects | GTP Phosphohydrolases - genetics | MAP Kinase Kinase 2 - antagonists & inhibitors | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Benzimidazoles - pharmacology | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Mutation | Niacinamide - pharmacology | Colorectal Neoplasms - pathology | Pyridones - pharmacology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article